SCOPUS 정보 검색 플랫폼

Volumn 45, Issue 4, 2001, Pages 275-283

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

(50) Pascual, Julio a,f Bussone, Gennaro b Hernandez, Jose Fernando c Allen, Christopher d Vrijens, France e Patel, Krupa d Alom, J f Atweh, S f Bermejo, F f Boccuni, M f Bussone, G f Carratelli, D f Carvalho, D f Cerbo, R f Chen, S T f Fadic, R f Faoro, A f Fernandez, O f Francisconi, C R M f Gallai, V f more..

a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA (Spain)

b Fondazione Istituto Neurologico (Italy)

c HOSPITAL MILITAR CENTRAL (Colombia)

d MERCK RESEARCH LABORATORIES (United States)

e Merck Sharp and Dohme (Belgium)

f Merck and Co Inc ^*

Author keywords

Migraine; Preference; Rizatriptan; Sumatriptan

Indexed keywords

RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG PREFERENCE; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PHOBIA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; SOMNOLENCE; THORAX PAIN; TREATMENT OUTCOME; VERTIGO; VOMITING;

EID: 17844405869 PISSN: 00143022 EISSN: None Source Type: Journal
DOI: 10.1159/000052143 Document Type: Article

Times cited : (39)

References (13)

1
- 0032987716
- Efficacy and safety of rizatriptan wafer for the acute treatment of migraine
- Rizatriptan Wafer Protocol 049 Study Group
- Cephalalgia
- (1999) Cephalalgia , vol.19 , pp. 525-530
- Ahrens, S.P.¹ Farmer, M.V.² Williams, D.L.³ Willoughby, E.⁴ Jiang, K.⁵ Block, G.A.⁶ Visser, W.H.⁷

2
- 0032423808
- Crossover comparison of rizatriptan 5 mg and 10 mg vs sumatriptan 25 mg and 50 mg in migraine
- Headache
- (1998) Headache , vol.38 , pp. 737-747
- Goldstein, J.¹ Ryan, R.² Jiang, K.³ Getson, A.⁴ Norman, B.⁵ Block, G.A.⁶ Lines, C.⁷

3
- 0032407703
- Oral rizatriptan versus oral sumatriptan: A randomised, comparative study in the acute treatment of migraine
- Headache
- (1998) Headache , vol.38 , pp. 748-755
- Tfelt-Hansen, P.¹ Teall, J.² Rodriguez, F.³ Giacovazzo, M.⁴ Paz, J.⁵ Malbecq, W.⁶ Block, G.A.⁷ Reines, S.A.⁸ Visser, W.H.⁹

4
- 85130340996
- WHO Collaborating Centre for Drug Statistics Methodology, February
- WHO Collaborating Centre for Drug Statistics Methodology
- (2000)

5
- 0346031709
- Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
- Headache Classification Committee of the International Headache Society
- Cephalalgia
- (1988) Cephalalgia , vol.8 , Issue.SUPPL. 7 , pp. 1-96

6
- 0003619146
- London, Chapman and Hall
- Design and Analysis of Cross-Over Trials
- (1989) Design and Analysis of Cross-Over Trials
- Jones, B.¹ Kenward, M.G.²

7
- 0015905420
- Marginal likelihood based on Cox's regression life models
- Biometrika
- (1973) Biometrika , vol.60 , pp. 267-268
- Kalbfleish, J.D.¹ Prentice, R.L.²

8
- 0029069912
- Development of a brief 24-hour migraine-specific quality of life questionnaire
- Headache
- (1995) Headache , vol.35 , pp. 320-329
- Hartmaier, S.L.¹ Santanello, N.C.² Epstein, R.S.³ Silberstein, S.D.⁴

9
- 0029069913
- Validation of a new quality of life questionnaire for acute migraine headache
- Headache
- (1995) Headache , vol.35 , pp. 330-337
- Santanello, N.C.¹ Hartmaier, S.L.² Epstein, R.S.³ Silberstein, S.D.⁴

10
- 0034113984
- Rizatriptan tablet versus wafer: Patient preference
- Headache
- (2000) Headache , vol.40 , pp. 371-372
- Adelman, J.U.¹ Mannix, L.K.² Von Seggern, R.L.³

11
- 0031899682
- Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study
- Rizatriptan 022 Study Group
- Headache
- (1998) Headache , vol.38 , pp. 281-287
- Teall, J.¹ Tuchman, M.² Cutler, N.³ Gross, M.⁴ Willoughby, E.⁵ Smith, B.⁶ Jiang, K.⁷ Reines, S.⁸ Block, G.⁹

12
- 0034483344
- Guidelines for controlled trials of drugs in migraine: Second edition
- Cephalalgia
- (2000) Cephalalgia , vol.20 , pp. 765-786
- Tfelt-Hansen, P.¹ Block, G.² Dahlof, C.³ Diener, H.C.⁴ Ferrari, M.D.⁵ Goadsby, P.J.⁶ Guidetti, V.⁷ Jones, B.⁸ Lipton, R.B.⁹ Massiou, H.¹⁰ Meinert, C.¹¹ Sandrini, G.¹² Steiner, T.¹³ Winter, P.B.¹⁴

13
- 0033169971
- Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: A double-blind, randomized, crossover study
- Sumatriptan Tablets S2CM11 Study Group
- Int J Clin Pract Suppl
- (1999) Int J Clin Pract Suppl , vol.105 , pp. 16-24
- Salonen, R.¹ Ashford, E.A.² Gibbs, M.³ Hassani, H.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.